These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21067897)
1. Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (≥ 65 years old). Itakura H; Nakaya N; Kusunoki T; Shimizu N; Hirai S; Mochizuki S; Ishikawa T J Cardiol; 2011 Jan; 57(1):77-88. PubMed ID: 21067897 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for cardiovascular events in Japanese patients treated with fluvastatin from the long-term event monitoring (LEM) study. Morishita R; Itakura H; Nakaya N; Yoshida M; Odawara M; Ichihara A; Mizuno K Curr Vasc Pharmacol; 2012 Mar; 10(2):178-86. PubMed ID: 21824105 [TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients. Ghods AJ; Milanian I; Arghani H; Ghadiri G Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835 [No Abstract] [Full Text] [Related]
4. Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of age. Bruckert E; Verpilleux MP; Dejager S; Isaacsohn J Am J Cardiol; 2005 Oct; 96(8):1142-8. PubMed ID: 16214453 [TBL] [Abstract][Full Text] [Related]
5. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
6. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia. Rindone JP; Hiller D; Arriola G Pharmacotherapy; 1998; 18(4):836-9. PubMed ID: 9692657 [TBL] [Abstract][Full Text] [Related]
7. Fluvastatin for lowering cholesterol. Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137 [No Abstract] [Full Text] [Related]
8. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients. Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients. Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469 [No Abstract] [Full Text] [Related]
10. Fluvastatin in renal transplantation. Hadjigavriel M; Kyriakides G Transplant Proc; 1997 Nov; 29(7):3050. PubMed ID: 9365661 [No Abstract] [Full Text] [Related]
11. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir. Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
13. Fluvastatin in combination with other lipid-lowering agents. Jokubaitis LA Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270 [TBL] [Abstract][Full Text] [Related]
14. Fluvastatin in combination with other lipid-lowering agents. Jokubaitis LA Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia. Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841 [TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group. Jacotot B; Banga JD; Waite R; Peters TK Am J Cardiol; 1995 Jul; 76(2):41A-46A. PubMed ID: 7604796 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database. Peters TK; Muratti EN; Mehra M Am J Med; 1994 Jun; 96(6A):79S-83S. PubMed ID: 8017471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]